Skip to main content

Table 6 The association between calculated threshold of main pancreatic duct (MPD) and malignancy in body-tail MPD-involved intraductal papillary mucinous neoplasms (IPMNs)

From: Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail

 

Univariate analysis

Multivariate analysis

OR

P value

OR

P value

MPD diameter (≥ 7.7 mm vs. < 7.7 mm)

4.71 (0.73–30.28)

0.102

8.78 (0.84–91.49)

0.07

Size (≥ 30 mm vs. < 30 mm)

0.60 (0.08–4.54)

0.621

0.24 (0.02–3.42)

0.27

CEA (≥ 5 vs. < 5 ng/ml)

0.71 (0.06–8.15)

0.79

0.52(0.04–7.23)

0.62

  1. CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, OR odds ratio
  2. Ca19-9 levels and presence of mural nodule were not included in the analysis because there were no cases with high CA19-9 (> 37 U/L) and presence of mural nodule in low-intermediate grade group. Then CEA was included in the models–